课题基金 / 基金详情

PHASE II OF CISPLATIN AND 5-FLUOROURACIL FOR PATIENTS WITH BREAST CANCER

PHASE II OF CISPLATIN AND 5-FLUOROURACIL FOR PATIENTS WITH BREAST CANCER
顺铂和 5-氟尿嘧啶用于乳腺癌患者的 II 期治疗
批准号：
3884853
负责人：
RONALD BLUM
金额：
$0.0万
依托单位：
NEW YORK UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3884853
关键词：
breast neoplasms cis platinum compound clinical trials combination chemotherapy drug adverse effect fluorouracil human subject human therapy evaluation metastasis remission /regression

项目摘要

项目成果

RONALD BLUM的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this study is to assess the therapeutic efficacy of Cisplatin and 5-Fluorouracil combination in metastatic breast cancer after failing one prior chemotherapy program; to assess the toxicity of Cisplatin and 5-Fluorouracil combination and to determine the response rates, duration of remission and survival of treated patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ECOG C9344 DOXORUBICIN DOSE ESCALATION +/- TAXOL FOR NODE POSITIVE BREAST CANCER
SWOG 94-20 CORRELATION OF THYMIDYLATE SYNTHASE IN 5 FU TREATED COLORECTAL CANCER
ECOG S9313--ADJUVANT CHEMOTHERAPY IN HIGH RISK BREAST CANCER PATIENTS
ECOG 91140--CDP, DTIC, CARMUSTINE & TAMOXIFEN VS DTIC IN ADVANCED MELANOMA